New JTH Research on Bleeding Risk in Pregnant Women Treated for Acute Venous Thromboembolism
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn:
“The risk of bleeding in pregnant women with acute venous thromboembolism treated with anticoagulants: an international multidatabase cohort study
This multinational study assessed bleeding risk in pregnant women treated with low-molecular-weight heparins (LMWH) for acute VTE. It found no significant difference in bleeding risk between LMWH types or dosing schedules, highlighting the need for further research to optimize anticoagulation care in pregnancy.”
Title: The risk of bleeding in pregnant women with acute venous thromboembolism treated with anticoagulants: an international multidatabase cohort study
Authors: Camille Simard, Isabelle Malhamé, Christopher Filliter, Annika Vivirito, Kristian B. Filion, Haim Abenhaim, Dirk Enders, Antonios Douros, Vicky Tagalakis
Read the full article here.
Find similar posts on Hemostasis Today.
-
Dec 18, 2025, 17:13Daria Camilli on EuroBloodNet and EHC Collaboration for Bleeding Disorders
-
Dec 18, 2025, 16:50Marie Cambot on Innovhem’s Quantification of The HbF/HbS Ratio for SCD
-
Dec 18, 2025, 16:26Yogesh Rathod on Hematological Issues and ICU
-
Dec 18, 2025, 16:09Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
-
Dec 18, 2025, 15:23Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals
-
Dec 18, 2025, 15:12Wolfgang Miesbach on Insights from Guy Young’s ASH2025 Session on Next-Generation Gene Therapy
-
Dec 18, 2025, 14:15Plasma-Derived Therapy for Hemophilia in The Updated European Medicines Agency’s Union List
-
Dec 18, 2025, 13:55Laurent Bertoletti: BAT-VTE is One of 7 Projects Funded Under the EFFECT Trial Call!
-
Dec 18, 2025, 13:34Alexandru Stieber Explores VEXAS Syndrome